INM vs JKHY · rev $4.9M vs P/E 30, rev $2.54B
InMed Pharmaceuticals Inc (INM) versus Jack Henry & Associates Inc (JKHY) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
INM currently screens at market cap $5.2M. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Not investment advice. Open the INM and JKHY stock pages for the full models.
Not investment advice.